ImmuCell Corporation
ICCC
$9.67
-$0.10-1.02%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -653.65% | 80.09% | 132.77% | 430.44% | 145.15% |
| Total Depreciation and Amortization | 4.82% | 0.59% | -0.42% | 1.30% | -0.16% |
| Total Amortization of Deferred Charges | -70.37% | 174.07% | 0.00% | 5.88% | 6.93% |
| Total Other Non-Cash Items | 8,683.90% | -330.92% | -72.30% | -56.29% | -67.86% |
| Change in Net Operating Assets | 82.58% | -149.95% | -70.53% | -528.25% | -234.83% |
| Cash from Operations | 15,664.52% | -84.98% | 175.27% | 276.06% | 99.57% |
| Capital Expenditure | 12.18% | -571.83% | -40.20% | -367.47% | -141.33% |
| Sale of Property, Plant, and Equipment | -- | -- | 548.89% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 14.73% | -569.68% | -18.55% | -367.47% | -680.47% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.45% | -205.27% | -4.67% | -5.15% | -4.88% |
| Issuance of Common Stock | -100.00% | -100.00% | -21.00% | -- | 2,768.62% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 86.82% | 84.89% | -760.00% | -197.59% |
| Cash from Financing | -365.01% | -110.51% | 31.54% | -10.12% | 146.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -57.54% | -185.03% | 284.47% | 4,671.20% | 95.01% |